Dr. Andrew W. Lo, a prominent economist, is the Charles E. and Susan T. Harris Professor at the MIT Sloan School of Management and director of the MIT Laboratory for Financial Engineering. He received his Ph.D. in economics from Harvard University in 1984. Before joining MIT’s finance faculty in 1988, he taught at the University of Pennsylvania’s Wharton School as the W.P. Carey Assistant Professor of Finance from 1984 to 1987, and as the W.P. Carey Associate Professor of Finance from 1987 to 1988.
Dr. Lo delivers keynote speech at the New England Chinese Professionals Lunar New Year gala on Feb. 1, 2014 (photo by David Li).
Dr. Lo has published numerous articles in finance and economics journals, and has authored several books including The Econometrics of Financial Markets, A Non-Random Walk Down Wall Street, Hedge Funds: An Analytic Perspective, and The Evolution of Technical Analysis. He is currently co-editor of the Annual Review of Financial Economics and an associate editor of the Financial Analysts Journal, the Journal of Portfolio Management, and the Journal of His awards include the Alfred P. Sloan Foundation Fellowship, the Paul A. Samuelson Award, the American Association for Individual Investors Award, the Graham and Dodd Award, the 2001 IAFE-SunGard Financial Engineer of the Year award, a Guggenheim Fellowship, the CFA Institute’s James R. Vertin Award, the 2010 Harry M. Markowitz Award, and awards for teaching excellence from both Wharton and MIT.
A former governor of the Boston Stock Exchange, Dr. Lo is currently a Research Associate of the National Bureau of Economic Research; a member of the OFR Financial Research Advisory Committee, the New York Federal Reserve Board’s Financial Advisory Roundtable, FINRA’s Economic Advisory Committee, the Consortium for Systemic Risk Analytics Academic Advisory Board, the Board on Mathematical Sciences and Their Applications, and Beth Israel Deaconess Medical Center’s Board of Overseers. He is founder and chief scientific officer of Alpha Simplex Group, LLC, a quantitative investment management company based in Cambridge, Massachusetts.
Dr. Lo is regarded as one of the most important innovators in finance. In 2012, Time magazine named him one of the world’s 100 most influential people. He has recently devised financing strategies to fund cancer and orphan drug discovery and development with reduced aggregate risk and increased return on investment. His current campaign to apply the financial engineering tools to curing deadly diseases has been well-received.